Clinical observation on effect of Salvia Miltiorrhiza Composita in preventing and treating ischemic coronary heart disease patients undergoing non-heart surgery

Zhou Suning; Duan Changli; Wei Qing; Shao Wei

doi:10.1007/BF02935393

Your Location：

Home >

Browse articles >

Clinical observation on effect of Salvia Miltiorrhiza Composita in preventing and treating ischemic coronary heart disease patients undergoing non-heart surgery

Updated：2021-08-27

- Clinical observation on effect of Salvia Miltiorrhiza Composita in preventing and treating ischemic coronary heart disease patients undergoing non-heart surgery
- Chinese Journal of Integrative Medicine Vol. 5, Issue 4, Pages: 247-249(1999)
- Affiliations：
  
  1. Shandong University of TCM,Jinan
  2. Qianfoshan Mountain Hospital of Shandong Province,Jinan
- Author bio：
- Funds：
- DOI：10.1007/BF02935393
  CLC：
- Published：1999，
Scan for full text
Suning, Z., Changli, D., Qing, W. et al. Clinical observation on effect of Salvia Miltiorrhiza Composita in preventing and treating ischemic coronary heart disease patients undergoing non-heart surgery., CJIM 5, 247–249 (1999). https://doi.org/10.1007/BF02935393

Zhou Suning, Duan Changli, Wei Qing, et al. Clinical observation on effect of Salvia Miltiorrhiza Composita in preventing and treating ischemic coronary heart disease patients undergoing non-heart surgery. [J]. Chinese Journal of Integrative Medicine 5(4):247-249(1999)
Suning, Z., Changli, D., Qing, W. et al. Clinical observation on effect of Salvia Miltiorrhiza Composita in preventing and treating ischemic coronary heart disease patients undergoing non-heart surgery., CJIM 5, 247–249 (1999). https://doi.org/10.1007/BF02935393 DOI：

Zhou Suning, Duan Changli, Wei Qing, et al. Clinical observation on effect of Salvia Miltiorrhiza Composita in preventing and treating ischemic coronary heart disease patients undergoing non-heart surgery. [J]. Chinese Journal of Integrative Medicine 5(4):247-249(1999) DOI： 10.1007/BF02935393.

摘要

Objective: To observe the preventing and treating effect of Salvia Miltiorrhiza Compsita (SMC) in patients with ischemic coronary heart disease (CHD) undergoing non-heart surgery.Methods: One hundred and eight patients were randomly divided into control group and treatment group. During operation

the control group was treated by heteropathy such as nitrate ester

while the treatment group was treated with SMC intravenously. ECG

heart rate (HR)

mean arterial pressure (MAP) and sphygmous blood oxygen saturation (SpO2) and quantity of blood loss were observed during and at the end of the operation. The efficacy of treatment was judged according to the change of ECG.Results: The total effective rate in the treatment group was 90.7% (49/54 cases)

while in the control group it was 35.2% (19/54 cases). There was significant difference between the two groups (P < 0. 01). HR of the patients in the treatment group was not changed significantly

but in the control group

it became faster (P < 0.05). No significant difference was found in MAP and SpO2 between the two groups

or in comparison of data before and after operation. Also no significant difference in quantity of blood loss was shown between the two groups.Conclusion: SMC could effectively protect heart function from myocardial ischemia in patients with CHD undergoing non-heart surgery

neither shows any side effect. Therefore

it is an effective and safe measure.

Abstract

the control group was treated by heteropathy such as nitrate ester

while the treatment group was treated with SMC intravenously. ECG

heart rate (HR)

while in the control group it was 35.2% (19/54 cases). There was significant difference between the two groups (P < 0. 01). HR of the patients in the treatment group was not changed significantly

but in the control group

it became faster (P < 0.05). No significant difference was found in MAP and SpO2 between the two groups

neither shows any side effect. Therefore

it is an effective and safe measure.

关键词

Salvia miltiorrhiza compositacoronary heart diseasenon-heart surgerymyocardial ischemia during operation

Keywords

Salvia miltiorrhiza compositacoronary heart diseasenon-heart surgerymyocardial ischemia during operation

references

FULL TEXT LINK

More>

Views

360

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Blood stasis syndrome of coronary heart disease: A perspective of modern medicine

Biomedical mechanisms of blood stasis syndrome of coronary heart disease by systems biology approaches

Study on correspondence between prescription and syndrome and the essence of phlegm and blood stasis syndrome in coronary heart disease based on metabonomics

Summary of 2011 Integrative Medical Doctors Conference

A multi-center randomized double-blind placebo-controlled trial of Xiongshao Capsule (芎芍胶囊) in preventing restenosis after percutaneous coronary intervention: A subgroup analysis of senile patients

Related Author

No data

Related Institution

Department of Cardiology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences

Academy of Chinese Medical Sciences

Department of Cardiology, Guang’anmen Hospital

Department of Integrative Cardiology, China-Japan Friendship Hospital

Guangdong Provincial Hospital of Chinese Medicine

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰